Is a presymptomatic malignant hyperthermia in-vitro diagnosis with 4-chloro-3-ethyl phenol possible? A study using porcine skeletal preparations

The diagnosis of malignant hyperthermia is currently performed with the in-vitro contracture test (IVCT) with halothane and caffeine. This test has a sensitivity of 99.0 % but only a specificity of 93.6 %. A cumulative IVCT with 4-chloro-3-ethyl-phenole (CEP) has recently been shown to differentiate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2004-02, Vol.39 (2), p.81-86
Hauptverfasser: Gerbershagen, M U, Wappler, F, Fiege, M, Weisshorn, R, Kolodzie, K, Schulte am Esch, J
Format: Artikel
Sprache:ger
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 86
container_issue 2
container_start_page 81
container_title Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
container_volume 39
creator Gerbershagen, M U
Wappler, F
Fiege, M
Weisshorn, R
Kolodzie, K
Schulte am Esch, J
description The diagnosis of malignant hyperthermia is currently performed with the in-vitro contracture test (IVCT) with halothane and caffeine. This test has a sensitivity of 99.0 % but only a specificity of 93.6 %. A cumulative IVCT with 4-chloro-3-ethyl-phenole (CEP) has recently been shown to differentiate between MH susceptible (MHS) and MH normal (MHN) swine. The pur-pose of this study was to investigate the ability of bolus CEP-applications to distinguish between porcine MHS- and MHN-muscle specimens using the IVCT. After approval by the local animal care committee 8 MHS- and 8 MHN-swine were anaesthetized and muscle biopsies taken. For IVCT, muscle specimens were exposed to bolus administration of CEP in concentrations of 75 resp. 100 micro mol l (-1). Predefined parameters were: (1) onset time of the contracture development, (2) time to the achievement of the 2, 5 and 10 mN contracture level and (3) maximum contracture level. Data are expressed as medians and ranges. After 75 micro mol l (-1) CEP administration all MHS-muscles showed contractures after 0.5 min (0.2 min/0.9 min). The 2 mN contracture level was reached by all MHS-, the 5 mN level by four MHS- and the 10 mN level by one MHS-specimen. The maximum contracture was 5.3 mN (2.4 mN/12.9 mN). The onset time after 100 micro mol l (-1) CEP was registered as 0.3 min (0.1 min/0.7 min) in the MHS-preparations. Again, the 2 mN level was achieved by all MHS-specimens, the 5 mN level by 5 and the 10 mN level by one MHS-bundle. The maximum contracture was measured as 5.9 mN (2.8 mN/13.9 mN). In 7 MHN-specimens no contracture development was measured. After 75 micro mol l (-1) CEP one MHN-muscle showed a maximum contracture of 1.0 mN, after 100 micro mol l (-1) CEP one MHN-bundle demonstrated a maximum contracture of 1.1 mN. Hence, a significant difference between MHS and MHN without overlap was revealed with both CEP-concentrations in the onset time of contracture, in the 2 mN contracture level and the maximum contracture. Since a clear differentiation between MHS and MHN porcine specimens was achieved after bolus application of 75 and 100 micro mol l (-1) CEP, MH-diagnosis might be possible with a CEP-IVCT. It seems worthwhile to examine this hypothesis in men.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_80148920</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80148920</sourcerecordid><originalsourceid>FETCH-LOGICAL-p547-292b9a72ef80ea7e44be060501759f11b2e4ab05cefb1b564d79e4d2ae32c03</originalsourceid><addsrcrecordid>eNo1kMtKxDAYhbtQnPHyCpKVu0CSps1kJcPgZWBAEPclaf9Oo2kSk1TpW_jIzuC4OnD4OB-cs2JJZCkxq2u6KC5TeieEshXjF8WCclELIcWy-NkmpFCIkOYxZD-qbFo0Kmv2TrmMhjlAzAPE0ShkHP4yOXrUGbV3PpmEvk0eEMftYH30uMSQh9miMIDzh_ApGW3hHq1RylM3oykZtz_0sTUOUPoAC1nZoz6oeFB7l66L817ZBDenvCpeHx_eNs949_K03ax3OFRcYCaZlkow6FcElADONZCaVISKSvaUagZcaVK10Guqq5p3QgLvmIKStaS8Ku7-RkP0nxOk3IwmtWCtcuCn1KwI5SvJjuDtCZz0CF0TohlVnJv_A8tfNiRvhg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80148920</pqid></control><display><type>article</type><title>Is a presymptomatic malignant hyperthermia in-vitro diagnosis with 4-chloro-3-ethyl phenol possible? A study using porcine skeletal preparations</title><source>MEDLINE</source><source>Thieme Connect Journals</source><creator>Gerbershagen, M U ; Wappler, F ; Fiege, M ; Weisshorn, R ; Kolodzie, K ; Schulte am Esch, J</creator><creatorcontrib>Gerbershagen, M U ; Wappler, F ; Fiege, M ; Weisshorn, R ; Kolodzie, K ; Schulte am Esch, J</creatorcontrib><description>The diagnosis of malignant hyperthermia is currently performed with the in-vitro contracture test (IVCT) with halothane and caffeine. This test has a sensitivity of 99.0 % but only a specificity of 93.6 %. A cumulative IVCT with 4-chloro-3-ethyl-phenole (CEP) has recently been shown to differentiate between MH susceptible (MHS) and MH normal (MHN) swine. The pur-pose of this study was to investigate the ability of bolus CEP-applications to distinguish between porcine MHS- and MHN-muscle specimens using the IVCT. After approval by the local animal care committee 8 MHS- and 8 MHN-swine were anaesthetized and muscle biopsies taken. For IVCT, muscle specimens were exposed to bolus administration of CEP in concentrations of 75 resp. 100 micro mol l (-1). Predefined parameters were: (1) onset time of the contracture development, (2) time to the achievement of the 2, 5 and 10 mN contracture level and (3) maximum contracture level. Data are expressed as medians and ranges. After 75 micro mol l (-1) CEP administration all MHS-muscles showed contractures after 0.5 min (0.2 min/0.9 min). The 2 mN contracture level was reached by all MHS-, the 5 mN level by four MHS- and the 10 mN level by one MHS-specimen. The maximum contracture was 5.3 mN (2.4 mN/12.9 mN). The onset time after 100 micro mol l (-1) CEP was registered as 0.3 min (0.1 min/0.7 min) in the MHS-preparations. Again, the 2 mN level was achieved by all MHS-specimens, the 5 mN level by 5 and the 10 mN level by one MHS-bundle. The maximum contracture was measured as 5.9 mN (2.8 mN/13.9 mN). In 7 MHN-specimens no contracture development was measured. After 75 micro mol l (-1) CEP one MHN-muscle showed a maximum contracture of 1.0 mN, after 100 micro mol l (-1) CEP one MHN-bundle demonstrated a maximum contracture of 1.1 mN. Hence, a significant difference between MHS and MHN without overlap was revealed with both CEP-concentrations in the onset time of contracture, in the 2 mN contracture level and the maximum contracture. Since a clear differentiation between MHS and MHN porcine specimens was achieved after bolus application of 75 and 100 micro mol l (-1) CEP, MH-diagnosis might be possible with a CEP-IVCT. It seems worthwhile to examine this hypothesis in men.</description><identifier>ISSN: 0939-2661</identifier><identifier>PMID: 14767797</identifier><language>ger</language><publisher>Germany</publisher><subject>Animals ; Chlorophenols ; In Vitro Techniques ; Malignant Hyperthermia - diagnosis ; Muscle Contraction - drug effects ; Muscle, Skeletal - drug effects ; Swine</subject><ispartof>Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2004-02, Vol.39 (2), p.81-86</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14767797$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gerbershagen, M U</creatorcontrib><creatorcontrib>Wappler, F</creatorcontrib><creatorcontrib>Fiege, M</creatorcontrib><creatorcontrib>Weisshorn, R</creatorcontrib><creatorcontrib>Kolodzie, K</creatorcontrib><creatorcontrib>Schulte am Esch, J</creatorcontrib><title>Is a presymptomatic malignant hyperthermia in-vitro diagnosis with 4-chloro-3-ethyl phenol possible? A study using porcine skeletal preparations</title><title>Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS</title><addtitle>Anasthesiol Intensivmed Notfallmed Schmerzther</addtitle><description>The diagnosis of malignant hyperthermia is currently performed with the in-vitro contracture test (IVCT) with halothane and caffeine. This test has a sensitivity of 99.0 % but only a specificity of 93.6 %. A cumulative IVCT with 4-chloro-3-ethyl-phenole (CEP) has recently been shown to differentiate between MH susceptible (MHS) and MH normal (MHN) swine. The pur-pose of this study was to investigate the ability of bolus CEP-applications to distinguish between porcine MHS- and MHN-muscle specimens using the IVCT. After approval by the local animal care committee 8 MHS- and 8 MHN-swine were anaesthetized and muscle biopsies taken. For IVCT, muscle specimens were exposed to bolus administration of CEP in concentrations of 75 resp. 100 micro mol l (-1). Predefined parameters were: (1) onset time of the contracture development, (2) time to the achievement of the 2, 5 and 10 mN contracture level and (3) maximum contracture level. Data are expressed as medians and ranges. After 75 micro mol l (-1) CEP administration all MHS-muscles showed contractures after 0.5 min (0.2 min/0.9 min). The 2 mN contracture level was reached by all MHS-, the 5 mN level by four MHS- and the 10 mN level by one MHS-specimen. The maximum contracture was 5.3 mN (2.4 mN/12.9 mN). The onset time after 100 micro mol l (-1) CEP was registered as 0.3 min (0.1 min/0.7 min) in the MHS-preparations. Again, the 2 mN level was achieved by all MHS-specimens, the 5 mN level by 5 and the 10 mN level by one MHS-bundle. The maximum contracture was measured as 5.9 mN (2.8 mN/13.9 mN). In 7 MHN-specimens no contracture development was measured. After 75 micro mol l (-1) CEP one MHN-muscle showed a maximum contracture of 1.0 mN, after 100 micro mol l (-1) CEP one MHN-bundle demonstrated a maximum contracture of 1.1 mN. Hence, a significant difference between MHS and MHN without overlap was revealed with both CEP-concentrations in the onset time of contracture, in the 2 mN contracture level and the maximum contracture. Since a clear differentiation between MHS and MHN porcine specimens was achieved after bolus application of 75 and 100 micro mol l (-1) CEP, MH-diagnosis might be possible with a CEP-IVCT. It seems worthwhile to examine this hypothesis in men.</description><subject>Animals</subject><subject>Chlorophenols</subject><subject>In Vitro Techniques</subject><subject>Malignant Hyperthermia - diagnosis</subject><subject>Muscle Contraction - drug effects</subject><subject>Muscle, Skeletal - drug effects</subject><subject>Swine</subject><issn>0939-2661</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kMtKxDAYhbtQnPHyCpKVu0CSps1kJcPgZWBAEPclaf9Oo2kSk1TpW_jIzuC4OnD4OB-cs2JJZCkxq2u6KC5TeieEshXjF8WCclELIcWy-NkmpFCIkOYxZD-qbFo0Kmv2TrmMhjlAzAPE0ShkHP4yOXrUGbV3PpmEvk0eEMftYH30uMSQh9miMIDzh_ApGW3hHq1RylM3oykZtz_0sTUOUPoAC1nZoz6oeFB7l66L817ZBDenvCpeHx_eNs949_K03ax3OFRcYCaZlkow6FcElADONZCaVISKSvaUagZcaVK10Guqq5p3QgLvmIKStaS8Ku7-RkP0nxOk3IwmtWCtcuCn1KwI5SvJjuDtCZz0CF0TohlVnJv_A8tfNiRvhg</recordid><startdate>200402</startdate><enddate>200402</enddate><creator>Gerbershagen, M U</creator><creator>Wappler, F</creator><creator>Fiege, M</creator><creator>Weisshorn, R</creator><creator>Kolodzie, K</creator><creator>Schulte am Esch, J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200402</creationdate><title>Is a presymptomatic malignant hyperthermia in-vitro diagnosis with 4-chloro-3-ethyl phenol possible? A study using porcine skeletal preparations</title><author>Gerbershagen, M U ; Wappler, F ; Fiege, M ; Weisshorn, R ; Kolodzie, K ; Schulte am Esch, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p547-292b9a72ef80ea7e44be060501759f11b2e4ab05cefb1b564d79e4d2ae32c03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Chlorophenols</topic><topic>In Vitro Techniques</topic><topic>Malignant Hyperthermia - diagnosis</topic><topic>Muscle Contraction - drug effects</topic><topic>Muscle, Skeletal - drug effects</topic><topic>Swine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gerbershagen, M U</creatorcontrib><creatorcontrib>Wappler, F</creatorcontrib><creatorcontrib>Fiege, M</creatorcontrib><creatorcontrib>Weisshorn, R</creatorcontrib><creatorcontrib>Kolodzie, K</creatorcontrib><creatorcontrib>Schulte am Esch, J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gerbershagen, M U</au><au>Wappler, F</au><au>Fiege, M</au><au>Weisshorn, R</au><au>Kolodzie, K</au><au>Schulte am Esch, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is a presymptomatic malignant hyperthermia in-vitro diagnosis with 4-chloro-3-ethyl phenol possible? A study using porcine skeletal preparations</atitle><jtitle>Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS</jtitle><addtitle>Anasthesiol Intensivmed Notfallmed Schmerzther</addtitle><date>2004-02</date><risdate>2004</risdate><volume>39</volume><issue>2</issue><spage>81</spage><epage>86</epage><pages>81-86</pages><issn>0939-2661</issn><abstract>The diagnosis of malignant hyperthermia is currently performed with the in-vitro contracture test (IVCT) with halothane and caffeine. This test has a sensitivity of 99.0 % but only a specificity of 93.6 %. A cumulative IVCT with 4-chloro-3-ethyl-phenole (CEP) has recently been shown to differentiate between MH susceptible (MHS) and MH normal (MHN) swine. The pur-pose of this study was to investigate the ability of bolus CEP-applications to distinguish between porcine MHS- and MHN-muscle specimens using the IVCT. After approval by the local animal care committee 8 MHS- and 8 MHN-swine were anaesthetized and muscle biopsies taken. For IVCT, muscle specimens were exposed to bolus administration of CEP in concentrations of 75 resp. 100 micro mol l (-1). Predefined parameters were: (1) onset time of the contracture development, (2) time to the achievement of the 2, 5 and 10 mN contracture level and (3) maximum contracture level. Data are expressed as medians and ranges. After 75 micro mol l (-1) CEP administration all MHS-muscles showed contractures after 0.5 min (0.2 min/0.9 min). The 2 mN contracture level was reached by all MHS-, the 5 mN level by four MHS- and the 10 mN level by one MHS-specimen. The maximum contracture was 5.3 mN (2.4 mN/12.9 mN). The onset time after 100 micro mol l (-1) CEP was registered as 0.3 min (0.1 min/0.7 min) in the MHS-preparations. Again, the 2 mN level was achieved by all MHS-specimens, the 5 mN level by 5 and the 10 mN level by one MHS-bundle. The maximum contracture was measured as 5.9 mN (2.8 mN/13.9 mN). In 7 MHN-specimens no contracture development was measured. After 75 micro mol l (-1) CEP one MHN-muscle showed a maximum contracture of 1.0 mN, after 100 micro mol l (-1) CEP one MHN-bundle demonstrated a maximum contracture of 1.1 mN. Hence, a significant difference between MHS and MHN without overlap was revealed with both CEP-concentrations in the onset time of contracture, in the 2 mN contracture level and the maximum contracture. Since a clear differentiation between MHS and MHN porcine specimens was achieved after bolus application of 75 and 100 micro mol l (-1) CEP, MH-diagnosis might be possible with a CEP-IVCT. It seems worthwhile to examine this hypothesis in men.</abstract><cop>Germany</cop><pmid>14767797</pmid><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0939-2661
ispartof Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2004-02, Vol.39 (2), p.81-86
issn 0939-2661
language ger
recordid cdi_proquest_miscellaneous_80148920
source MEDLINE; Thieme Connect Journals
subjects Animals
Chlorophenols
In Vitro Techniques
Malignant Hyperthermia - diagnosis
Muscle Contraction - drug effects
Muscle, Skeletal - drug effects
Swine
title Is a presymptomatic malignant hyperthermia in-vitro diagnosis with 4-chloro-3-ethyl phenol possible? A study using porcine skeletal preparations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T20%3A33%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20a%20presymptomatic%20malignant%20hyperthermia%20in-vitro%20diagnosis%20with%204-chloro-3-ethyl%20phenol%20possible?%20A%20study%20using%20porcine%20skeletal%20preparations&rft.jtitle=An%C3%A4sthesiologie,%20Intensivmedizin,%20Notfallmedizin,%20Schmerztherapie%20:%20AINS&rft.au=Gerbershagen,%20M%20U&rft.date=2004-02&rft.volume=39&rft.issue=2&rft.spage=81&rft.epage=86&rft.pages=81-86&rft.issn=0939-2661&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E80148920%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80148920&rft_id=info:pmid/14767797&rfr_iscdi=true